Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Pappas

Showing results (21-30 of 176) with videos related to

Pageof 18
Sort By:
Current Infectious Disease Reports|February 11, 2011
Cryptococcal meningitis: current approaches to management in patients with and without AIDSKyle D Brizendine, Peter G Pappas
Clinics in Chest Medicine|April 21, 2009
Blastomycosis: new insights into diagnosis, prevention, and treatmentJames A McKinnell, Peter G Pappas
Drugs|July 22, 2005
Antifungal combination therapy: clinical potentialJohn W Baddley, Peter G Pappas
Current Infectious Disease Reports|November 15, 2007
Combination antifungal therapy for the treatment of invasive yeast and mold infectionsJohn W Baddley, Peter G Pappas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2019
Histoplasmosis: Time to Redraw the Map and Up Our GameDavid S McKinsey, Peter G Pappas
Drugs|April 12, 2013
Cryptococcal infections: changing epidemiology and implications for therapyRicardo M La Hoz, Peter G Pappas
Clinical Transplantation|November 20, 2002
Fungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical featuresJohn W Baddley, Donna Salzman, Peter G Pappas
Medical Mycology Case Reports|January 17, 2014
Prototheca wickerhamii algaemia presenting as cholestatic hepatitis in a patient with systemic lupus erythematosus: A case report and literature reviewZaw Min, Stephen A Moser, Peter G Pappas
Antimicrobial Agents and Chemotherapy|December 12, 2024
New Perspectives on Antimicrobial Agents: RezafunginNicholas M Forrister, Todd P McCarty, Peter G Pappas
Infectious Disease Clinics of North America|May 21, 2021
Candidemia and Invasive CandidiasisTodd P McCarty, Cameron M White, Peter G Pappas
Pageof 18

Showing results (21-30 of 176) with videos related to

Sort By:
Pageof 18
Current Infectious Disease Reports|February 11, 2011
Cryptococcal meningitis: current approaches to management in patients with and without AIDSKyle D Brizendine, Peter G Pappas
Clinics in Chest Medicine|April 21, 2009
Blastomycosis: new insights into diagnosis, prevention, and treatmentJames A McKinnell, Peter G Pappas
Drugs|July 22, 2005
Antifungal combination therapy: clinical potentialJohn W Baddley, Peter G Pappas
Current Infectious Disease Reports|November 15, 2007
Combination antifungal therapy for the treatment of invasive yeast and mold infectionsJohn W Baddley, Peter G Pappas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2019
Histoplasmosis: Time to Redraw the Map and Up Our GameDavid S McKinsey, Peter G Pappas
Drugs|April 12, 2013
Cryptococcal infections: changing epidemiology and implications for therapyRicardo M La Hoz, Peter G Pappas
Clinical Transplantation|November 20, 2002
Fungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical featuresJohn W Baddley, Donna Salzman, Peter G Pappas
Medical Mycology Case Reports|January 17, 2014
Prototheca wickerhamii algaemia presenting as cholestatic hepatitis in a patient with systemic lupus erythematosus: A case report and literature reviewZaw Min, Stephen A Moser, Peter G Pappas
Antimicrobial Agents and Chemotherapy|December 12, 2024
New Perspectives on Antimicrobial Agents: RezafunginNicholas M Forrister, Todd P McCarty, Peter G Pappas
Infectious Disease Clinics of North America|May 21, 2021
Candidemia and Invasive CandidiasisTodd P McCarty, Cameron M White, Peter G Pappas
Pageof 18